Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived  -glucans

Induction of Innate Immune Response through TLR2 and Dectin 1 Prevents Type 1 Diabetes

(2014) S. Karumuthil-Melethil et al.   JOURNAL OF IMMUNOLOGY

Differential Use of CARD9 by Dectin-1 in Macrophages and Dendritic Cells

(2014) H. S. Goodridge et al.   JOURNAL OF IMMUNOLOGY

Optimized combination therapy using bortezomib, TRAIL and TLR agonists in established breast tumors

(2010) Sujin Lee et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

IL-17 Enhances Tumor Development in Carcinogen-Induced Skin Cancer

(2010) L. Wang et al.   CANCER RESEARCH

Orally Administered Particulate  -Glucan Modulates Tumor-Capturing Dendritic Cells and Improves Antitumor T-Cell Responses in Cancer

(2010) B. Li et al.   CLINICAL CANCER RESEARCH

Dendritic Cells in Lupus Are Not Required for Activation of T and B Cells but Promote Their Expansion, Resulting in Tissue Damage

(2010) Lino L. Teichmann et al.   IMMUNITY

The CD8+dendritic cell subset

(2010) Ken Shortman et al.   IMMUNOLOGICAL REVIEWS

Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice

(2010) Qing Zhu et al.   JOURNAL OF CLINICAL INVESTIGATION

HMGB1-derived peptide acts as adjuvant inducing immune responses to peptide and protein antigen

(2010) R. Saenz et al.   VACCINE

Role of GM-CSF signaling in cell-based tumor immunization

(2009) S. Zarei et al.   BLOOD

Endogenous IL-17 contributes to reduced tumor growth and metastasis

(2009) I. Kryczek et al.   BLOOD

Combined yeast-derived β-glucan with anti-tumor monoclonal antibody for cancer immunotherapy

(2009) Jingjing Liu et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Toll-like receptor agonists in cancer therapy

(2009) Sylvia Adams   Immunotherapy

Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer

(2009) Mary L. Disis et al.   JOURNAL OF CLINICAL ONCOLOGY

Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36

(2009) Terry K. Means et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Human Dectin-1 Deficiency and Mucocutaneous Fungal Infections

(2009) Bart Ferwerda et al.   NEW ENGLAND JOURNAL OF MEDICINE

Targeting of antigens to B cells augments antigen-specific T-cell responses and breaks immune tolerance to tumor-associated antigen MUC1

(2008) C. Ding et al.   BLOOD

Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses

(2008) S. LeibundGut-Landmann et al.   BLOOD

Yeast-Derived  -Glucan Augments the Therapeutic Efficacy Mediated by Anti-Vascular Endothelial Growth Factor Monoclonal Antibody in Human Carcinoma Xenograft Models

(2008) C. Salvador et al.   CLINICAL CANCER RESEARCH

DC activated via dectin-1 convert Treg into IL-17 producers

(2008) Fabiola Osorio et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Differential High-Affinity Interaction of Dectin-1 with Natural or Synthetic Glucans Is Dependent upon Primary Structure and Is Influenced by Polymer Chain Length and Side-Chain Branching

(2008) E. L. Adams et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS